Pfizer reports positive 26-week REFLECTIONS B328-06 study results
Pfizer has reported positive 26-week data from the ongoing Phase III REFLECTIONS B328-06 trial evaluating the safety and efficacy of…
Pfizer REFLECTIONS B328-06 study
Pfizer has reported positive 26-week data from the ongoing Phase III REFLECTIONS B328-06 trial evaluating the safety and efficacy of…